Diagnosis, Prevention, and Treatment of Leishmaniasis and Chagas Disease: Focus on Latin American Context

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Parasitic Pathogens".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 41

Special Issue Editors


E-Mail Website
Guest Editor
Laboratório de Biotecnologia de Microrganismos, Universidade Federal de São João Del-Rei (UFSJ) Campus Centro-Oeste, Divinópolis 35501-296, MG, Brazil
Interests: microbial biotechnology; molecular biology; recombinant proteins; immunodiagnostics; leishmaniasis; chagas
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Laboratório de Biologia das Interações Celulares, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil
Interests: leishmaniasis; vaccine; immunology; diagnosis; chagas
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vector-borne parasitic diseases such as leishmaniasis and Chagas disease pose significant public health challenges worldwide, particularly in tropical and subtropical regions. Leishmaniasis, caused by the protozoan parasite Leishmania infantum, is a zoonotic disease primarily transmitted by sand flies, with dogs serving as the main reservoir for the canine form of the disease. Chagas disease, caused by Trypanosoma cruzi, is transmitted by triatomine bugs and affects millions of people. These diseases are characterized by a wide range of clinical manifestations, from asymptomatic infections to severe, life-threatening complications, highlighting the need for comprehensive strategies to combat them.

Recent innovations have transformed the management of vector-borne parasitic diseases. Diagnostic advancements include recombinant proteins like rMELEISH, which improve the serological test accuracy for leishmaniasis. Computer-aided drug design (CADD) accelerates therapeutic discovery by optimizing drug–target interactions. As a form of prevention, chimeric protein vaccines and nanoparticles boost immunity and hinder parasite transmission. Additionally, novel vector control methods, such as insecticide-impregnated collars, effectively reduce disease prevalence.

The aim of this Special Issue is to provide a comprehensive platform for insights relating to the field of vector-borne parasitic diseases. We invite submissions of various types, including original research articles, comprehensive reviews, communications, and case reports.

Dr. Alexsandro Sobreira Galdino
Dr. Rodolfo Cordeiro Giunchetti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vector-borne parasitic diseases
  • leishmaniasis
  • Chagas disease
  • recombinant proteins
  • drug design
  • vaccine development
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop